It will be of interest in future studies to evaluate the role of tau regulation in different epilepsy syndromes as well as in dual diagnosed AD + epilepsy cases across the disease spectrum, evaluating clinical variables like seizure frequency and clinical/subclinical epileptiform abnormalities. This evidence concerns the gene MAPT and Alzheimer disease.